1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Bristol Myers Squibb Patient Assistance Foundation Program is sponsored by Bristol-Myers Squibb Patient Assistance Foundation Inc.. This program provides certain Bristol Myers Squibb medicines free of charge to eligible patients who face financial hardship and have no other insurance coverage for their prescribed medications. The foundation provides a 90-day supply of medicine per shipment to the patient's healthcare provider.
Geographic focus: United States, Puerto Rico, and U.S. Virgin Islands
Focus areas: Healthcare Access, Medication Assistance, Patient Support
Get alerted about grants like this
Save a search for “Bristol-Myers Squibb Patient Assistance Foundation Inc.” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# Patient Assistance Foundation Do you need to Reapply for Assistance? Please **click here** for more information. * Eligibility Requirements # We provide certain Bristol Myers Squibb medicines to eligible patients free of charge.
## What is the Bristol Myers Squibb Patient Assistance Foundation? The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) is an independent, charitable organization that helps eligible patients who need temporary help obtaining the medicines listed on this website. Find out if the medicine your doctor prescribed is available through the Bristol Myers Squibb Patient Assistance Foundation.
See which medicines are available Complete a brief assessment to see if you might be eligible for assistance. Check your eligibility We'll need some information from both you and your doctor to process your application. Learn how to apply Questions?
1-800-736-0003 Our program associates are available: 8:00 AM - 8:00 PM ET (excluding holidays) ABRAXANE®, AUGTYRO®, CAMZYOS®, COBENFY™, ELIQUIS® EMPLICITI®, IDHIFA®, INREBIC®, ISTODAX®, KRAZATI®, NULOJIX®, ONUREG®, OPDIVO®, OPDIVO QVANTIG™, OPDUALAG®, ORENCIA®, POMALYST®, REBLOZYL®, REVLIMID®, SOTYKTU®, SPRYCEL®, THALOMID®, VIDAZA®, YERVOY®, and ZEPOSIA® are trademarks of Bristol-Myers Squibb Company and/or one of its subsidiaries.
* PAF-NO-US-2400004 11/25 ## For Patients Applying to the Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) **Note to Medicare Patients:** In addition to your application, you will need to submit documentation showing you have spent at least 3% of your annual household income on out-of-pocket prescription expenses in the same calendar year you are applying to BMSPAF.
Your pharmacy or your Medicare Plan can provide you with your year-to-date out-of-pocket expenses. **This 3% out-of-pocket prescription expense is in addition to our other eligibility criteria, including financial eligibility. We may not be able to process your application until we receive documentation of these out-of-pocket prescription expenses.
** Your Opt Out Preference Signal is Honored - [x] checkbox label label - [x] checkbox label label - [x] checkbox label label - [x] checkbox label label
Based on current listing details, eligibility includes: Applicants must reside in the United States, Puerto Rico, or the U.S. Virgin Islands; be under the care of a U.S. licensed physician; have a valid prescription for a supported medication; meet specific annual household income limits (typically based on the Federal Poverty Level); and have no prescription drug insurance coverage, or if enrolled in Medicare Part D, have spent at least 3% of their annual household income on out-of-pocket prescription expenses. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.